+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bio-Pharmaceutical Logistics Market by Product Type, Service Type, Mode of Transport, Temperature Requirement, End User - Global Forecast 2026-2032- Product Image
Bio-Pharmaceutical Logistics Market by Product Type, Service Type, Mode of Transport, Temperature Requirement, End User - Global Forecast 2026-2032- Product Image
Sale

Bio-Pharmaceutical Logistics Market by Product Type, Service Type, Mode of Transport, Temperature Requirement, End User - Global Forecast 2026-2032

  • Report

  • 198 Pages
  • June 2026
  • Region: Global
  • 360iResearch™
  • ID: 4904733
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Bio-Pharmaceutical Logistics Market is projected to reach USD 102.56 Billion in 2026. It is expected to continue growing at a CAGR of 12.31%, reaching USD 206.44 Billion by 2032.

Bio-pharmaceutical logistics has become a strategic growth engine for life sciences organizations as biologics, vaccines, cell and gene therapies, clinical trial materials, and specialty medicines require validated temperature control, chain-of-custody visibility, and regulatory-ready documentation. Unlike conventional freight, bio-pharma supply chains must protect product identity, potency, sterility, and patient safety across controlled ambient, refrigerated, frozen, and ultra-low-temperature lanes.

The sector is being shaped by measurable healthcare demand, stricter good distribution practice requirements, and the expansion of high-value therapies. The WHO has consistently emphasized that vaccine quality depends on effective cold-chain management, while regulators such as the U.S. FDA and European authorities continue to elevate expectations around serialization, traceability, quality systems, and data integrity. As a result, pharmaceutical logistics providers are competing on validated cold chain packaging, lane qualification, real-time monitoring, deviation management, and resilient global network design.

Transformative Shifts in the Logistics Landscape

The bio-pharmaceutical logistics landscape is shifting from shipment execution to end-to-end product stewardship. Growth in biologics, biosimilars, GLP-1 therapies, oncology medicines, vaccines, and advanced therapy medicinal products is increasing demand for temperature-controlled warehousing, specialty courier services, cryogenic handling, and direct-to-patient distribution models.

At the same time, supply chain leaders are redesigning networks for resilience after pandemic-era disruption, geopolitical risk, extreme weather, and capacity volatility exposed weaknesses in long, single-source distribution routes. Compliance frameworks such as EU Good Distribution Practice, U.S. Drug Supply Chain Security Act requirements, IATA pharmaceutical handling standards, and national import controls are driving investment in traceability, validated packaging, qualified carriers, quality agreements, and digital control towers.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is compounding gains across bio-pharmaceutical logistics by improving demand forecasting, route optimization, temperature excursion prediction, warehouse labor planning, customs document review, and exception management. When AI models are connected to IoT sensors, GPS telemetry, weather feeds, airline schedules, customs milestones, inventory records, and quality data, logistics teams can move from reactive intervention to predictive risk mitigation.

The strongest use cases are practical and auditable: AI-assisted lane qualification, automated deviation triage, predictive maintenance for cold rooms and refrigerated vehicles, dynamic packaging selection, inventory positioning, and document intelligence for customs and quality release. However, adoption must remain aligned with GxP validation, cybersecurity controls, data integrity principles, explainability, and human oversight because AI recommendations can affect regulated product quality and patient outcomes.

Key Regional Insights

Asia-Pacific is expanding rapidly as China, India, Japan, South Korea, Australia, and ASEAN markets scale biologics manufacturing, clinical trials, vaccine distribution, and specialty medicine access. The region’s diverse geography, rising healthcare investment, and increasing participation in global clinical development are making temperature-controlled pharmaceutical logistics, validated packaging, and import-export compliance central priorities. North America remains a high-value hub due to the United States’ advanced therapy pipeline, DSCSA-driven traceability, strong third-party logistics infrastructure, and Canada’s GDP-aligned cold-chain standards across long-distance healthcare distribution routes.

Europe benefits from harmonized EU GDP expectations, dense cross-border healthcare distribution, established serialization requirements, and mature pharmaceutical manufacturing clusters in Germany, France, Italy, Spain, and the United Kingdom. Latin America is strengthening cold-chain capability around Brazil and Mexico, although infrastructure variability, security considerations, and customs complexity make lane validation critical. The Middle East is becoming a strategic transit and healthcare logistics hub through GCC investments in airports, free zones, and life sciences infrastructure, while Africa’s opportunity is tied to vaccine access, regional cold storage, public health programs, and last-mile reliability improvements supported by international immunization and healthcare supply initiatives.

Key Group Insights

ASEAN is gaining importance as pharmaceutical companies diversify manufacturing and clinical supply chains across Singapore, Malaysia, Thailand, Indonesia, Vietnam, and the Philippines, with regional growth supported by healthcare spending, trade connectivity, and improving cold-chain assets. The GCC is positioning itself as a temperature-controlled distribution bridge between Europe, Asia, and Africa, supported by airport cargo capacity, logistics parks, free-zone infrastructure, and national healthcare modernization programs.

The European Union provides one of the most structured regulatory environments for bio-pharmaceutical logistics through GDP guidance, Falsified Medicines Directive serialization, pharmacovigilance expectations, and cross-border market access. BRICS economies are central to long-term demand because they combine large patient populations with expanding domestic pharmaceutical production, public health distribution needs, and growing biologics capabilities. G7 markets remain the innovation and reimbursement anchors for high-value biologics, vaccines, and advanced therapies, while NATO-aligned logistics capabilities can influence resilience planning, emergency preparedness, secure medical supply routes, and contingency logistics for critical healthcare products.

Key Country Insights

The United States leads in specialty logistics complexity due to advanced therapies, specialty pharmacy distribution, decentralized clinical trial models, and FDA DSCSA package-level traceability requirements. Canada emphasizes quality-assured cold-chain distribution across long distances and variable climates, while Mexico is gaining relevance through nearshoring, pharmaceutical manufacturing, and cross-border healthcare logistics. Brazil anchors Latin American demand with a large healthcare system, immunization programs, and growing biologics adoption.

In Europe, the United Kingdom remains a clinical research and specialty distribution hub, Germany combines pharmaceutical manufacturing strength with advanced logistics infrastructure, France maintains strong public health and biopharma capacity, Russia requires careful risk, sanctions, and compliance management, and Italy and Spain support mature pharmaceutical manufacturing and hospital distribution networks. In Asia-Pacific, China and India are critical manufacturing and demand centers with expanding biologics and vaccine capabilities, Japan prioritizes high-quality regulated distribution and precise cold-chain execution, Australia requires robust long-distance cold-chain planning across dispersed population centers, and South Korea is becoming a major biopharma manufacturing and clinical supply market supported by advanced healthcare infrastructure.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize validated cold-chain network design, supplier qualification, quality agreements, and lane-level risk assessment before expanding capacity. Investments in real-time temperature monitoring, reusable and qualified packaging, automated quality documentation, and GDP-compliant warehousing deliver measurable value by reducing excursions, shortening release cycles, improving deviation control, and strengthening audit readiness.

Companies should also establish AI governance, integrate control tower data with quality management systems, and develop contingency routes for customs delays, carrier disruptions, temperature excursions, product recalls, and extreme weather. Strategic partnerships with certified carriers, specialty couriers, airlines, packaging providers, clinical supply specialists, and regional healthcare distributors are essential for scaling global reach without compromising product integrity, regulatory compliance, or patient safety.

Research Methodology

This executive summary is built using a structured research methodology that combines secondary research, regulatory review, market mapping, and expert interpretation. Sources include public guidance from health authorities, GDP and GxP frameworks, customs and trade references, logistics certification programs, healthcare infrastructure indicators, pharmaceutical supply chain standards, and public data on manufacturing, clinical trials, immunization, and healthcare access.

Insights are validated through triangulation across regulatory evidence, operational benchmarks, regional logistics conditions, and demand signals from pharmaceutical manufacturing, clinical development, biologics adoption, specialty medicine distribution, and public health programs. The methodology emphasizes data-backed conclusions, avoids unsupported market claims, and focuses on factors that materially affect bio-pharmaceutical logistics performance, compliance, resilience, and patient-centric delivery.

Conclusion

Bio-pharmaceutical logistics is evolving into a highly specialized discipline where quality assurance, digital visibility, regulatory compliance, and network resilience determine competitive advantage. As medicines become more personalized, temperature-sensitive, high-value, and time-critical, logistics providers and pharmaceutical manufacturers must manage every shipment as a regulated extension of the product lifecycle.

Organizations that combine validated infrastructure, AI-enabled risk management, global compliance expertise, qualified partner ecosystems, and regional execution strength will be best positioned to serve the next generation of biologics, vaccines, clinical trial materials, and advanced therapies. The sector’s direction is clear: patient safety, product integrity, and data-driven logistics excellence will define leadership.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Bio-Pharmaceutical Logistics Market, by Product Type
7.1. Biologics
7.2. Blood Products
7.3. Vaccines
8. Bio-Pharmaceutical Logistics Market, by Service Type
8.1. Cold Chain Packaging
8.2. Customs Clearance
8.3. Freight Forwarding
8.4. Storage And Distribution
8.5. Value Added Services
8.5.1. Kitting Services
8.5.2. Labeling Services
8.5.3. Quality Inspection
9. Bio-Pharmaceutical Logistics Market, by Mode Of Transport
9.1. Air
9.2. Rail
9.3. Road
9.4. Sea
10. Bio-Pharmaceutical Logistics Market, by Temperature Requirement
10.1. Ambient
10.2. Cryogenic
10.3. Frozen
10.4. Refrigerated
11. Bio-Pharmaceutical Logistics Market, by End User
11.1. Clinics
11.2. Contract Research Organizations
11.3. Hospitals
11.4. Pharmaceutical Companies
11.5. Research Institutes
12. Asia-Pacific Bio-Pharmaceutical Logistics Market
13. Europe Bio-Pharmaceutical Logistics Market
14. North America Bio-Pharmaceutical Logistics Market
15. Latin America Bio-Pharmaceutical Logistics Market
16. Africa Bio-Pharmaceutical Logistics Market
17. Middle East Bio-Pharmaceutical Logistics Market
18. NATO Bio-Pharmaceutical Logistics Market
19. G7 Bio-Pharmaceutical Logistics Market
20. BRICS Bio-Pharmaceutical Logistics Market
21. European Union Bio-Pharmaceutical Logistics Market
22. ASEAN Bio-Pharmaceutical Logistics Market
23. GCC Bio-Pharmaceutical Logistics Market
24. China Bio-Pharmaceutical Logistics Market
25. United States Bio-Pharmaceutical Logistics Market
26. Japan Bio-Pharmaceutical Logistics Market
27. India Bio-Pharmaceutical Logistics Market
28. Germany Bio-Pharmaceutical Logistics Market
29. United Kingdom Bio-Pharmaceutical Logistics Market
30. Australia Bio-Pharmaceutical Logistics Market
31. France Bio-Pharmaceutical Logistics Market
32. South Korea Bio-Pharmaceutical Logistics Market
33. Italy Bio-Pharmaceutical Logistics Market
34. Canada Bio-Pharmaceutical Logistics Market
35. Russia Bio-Pharmaceutical Logistics Market
36. Brazil Bio-Pharmaceutical Logistics Market
37. Mexico Bio-Pharmaceutical Logistics Market
38. Spain Bio-Pharmaceutical Logistics Market
39. Competitive Landscape
39.1. Market Concentration Analysis, 2025
39.1.1. Concentration Ratio (CR)
39.1.2. Herfindahl Hirschman Index (HHI)
39.2. Recent Developments & Impact Analysis, 2025
39.3. Product Portfolio Analysis, 2025
39.4. Benchmarking Analysis, 2025
40. Company Profiles
40.1. Agility Public Warehousing Company K.S.C.P.
40.2. Air Canada Cargo Inc.
40.3. Almac Group Limited
40.4. AmerisourceBergen Corporation
40.5. Biocair Limited
40.6. C.H. Robinson Worldwide, Inc.
40.7. Cardinal Health, Inc.
40.8. CEVA Logistics AG
40.9. Cryoport Inc.
40.10. DB Schenker
40.11. DHL Group
40.12. DSV Panalpina A/S
40.13. FedEx Corporation
40.14. GEODIS S.A.
40.15. Kerry Logistics Network Limited
40.16. Kuehne + Nagel International AG
40.17. MNX Global Logistics LLC
40.18. Movianto Group
40.19. Nippon Express Co., Ltd.
40.20. PCI Pharma Services Holdings LLC
40.21. QuickSTAT Global Life Science Logistics Inc.
40.22. SF Express Co., Ltd.
40.23. Thermo Fisher Scientific Inc.
40.24. United Parcel Service, Inc.
40.25. World Courier Inc.
List of Figures
FIGURE 1. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 7. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 9. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 13. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
FIGURE 14. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 15. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2025 VS 2032 (%)
FIGURE 17. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2025 VS 2032 (%)
FIGURE 19. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2025 VS 2032 (%)
FIGURE 21. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 23. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. ASIA-PACIFIC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 25. ASIA-PACIFIC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. EUROPE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 27. EUROPE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. NORTH AMERICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 29. NORTH AMERICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 30. LATIN AMERICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 31. LATIN AMERICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 32. AFRICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 33. AFRICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 34. MIDDLE EAST BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 35. MIDDLE EAST BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 36. NATO BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 37. NATO BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 38. G7 BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 39. G7 BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 40. BRICS BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 41. BRICS BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 42. EUROPEAN UNION BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 43. EUROPEAN UNION BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 44. ASEAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 45. ASEAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 46. GCC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 47. GCC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 48. CHINA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 49. UNITED STATES BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 50. JAPAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 51. INDIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 52. GERMANY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 53. UNITED KINGDOM BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 54. AUSTRALIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 55. FRANCE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 56. SOUTH KOREA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 57. ITALY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 58. CANADA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 59. RUSSIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 60. BRAZIL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 61. MEXICO BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 62. SPAIN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SHARE, BY KEY PLAYER, 2025
TABLE 7. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
TABLE 8. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL BIOLOGICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL BIOLOGICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL BLOOD PRODUCTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL BLOOD PRODUCTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL BLOOD PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL COLD CHAIN PACKAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL COLD CHAIN PACKAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL COLD CHAIN PACKAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL CUSTOMS CLEARANCE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL CUSTOMS CLEARANCE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL CUSTOMS CLEARANCE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL FREIGHT FORWARDING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL FREIGHT FORWARDING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL FREIGHT FORWARDING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL STORAGE AND DISTRIBUTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL STORAGE AND DISTRIBUTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL STORAGE AND DISTRIBUTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL VALUE ADDED SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL VALUE ADDED SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL VALUE ADDED SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL KITTING SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL KITTING SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL KITTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL LABELING SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL LABELING SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL LABELING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL QUALITY INSPECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL QUALITY INSPECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL QUALITY INSPECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL AIR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL AIR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL AIR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL RAIL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL RAIL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL RAIL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL ROAD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL ROAD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL ROAD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL SEA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL SEA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL SEA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL AMBIENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL AMBIENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL AMBIENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL CRYOGENIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL CRYOGENIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL CRYOGENIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL FROZEN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL FROZEN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL FROZEN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL REFRIGERATED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL REFRIGERATED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL REFRIGERATED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. ASIA-PACIFIC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. ASIA-PACIFIC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 87. ASIA-PACIFIC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 88. ASIA-PACIFIC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2018-2032 (USD MILLION)
TABLE 89. ASIA-PACIFIC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
TABLE 90. ASIA-PACIFIC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
TABLE 91. ASIA-PACIFIC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 92. EUROPE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. EUROPE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 94. EUROPE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 95. EUROPE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2018-2032 (USD MILLION)
TABLE 96. EUROPE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
TABLE 97. EUROPE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
TABLE 98. EUROPE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 99. NORTH AMERICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 100. NORTH AMERICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 101. NORTH AMERICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 102. NORTH AMERICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2018-2032 (USD MILLION)
TABLE 103. NORTH AMERICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
TABLE 104. NORTH AMERICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
TABLE 105. NORTH AMERICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 106. LATIN AMERICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 107. LATIN AMERICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 108. LATIN AMERICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 109. LATIN AMERICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2018-2032 (USD MILLION)
TABLE 110. LATIN AMERICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
TABLE 111. LATIN AMERICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
TABLE 112. LATIN AMERICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 113. AFRICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 114. AFRICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 115. AFRICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 116. AFRICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2018-2032 (USD MILLION)
TABLE 117. AFRICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
TABLE 118. AFRICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
TABLE 119. AFRICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 120. MIDDLE EAST BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 121. MIDDLE EAST BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 122. MIDDLE EAST BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 123. MIDDLE EAST BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2018-2032 (USD MILLION)
TABLE 124. MIDDLE EAST BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
TABLE 125. MIDDLE EAST BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
TABLE 126. MIDDLE EAST BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 127. NATO BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 128. NATO BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 129. NATO BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 130. NATO BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2018-2032 (USD MILLION)
TABLE 131. NATO BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
TABLE 132. NATO BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
TABLE 133. NATO BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 134. G7 BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 135. G7 BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 136. G7 BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 137. G7 BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2018-2032 (USD MILLION)
TABLE 138. G7 BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
TABLE 139. G7 BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
TABLE 140. G7 BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 141. BRICS BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 142. BRICS BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 143. BRICS BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 144. BRICS BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2018-2032 (USD MILLION)
TABLE 145. BRICS BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
TABLE 146. BRICS BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
TABLE 147. BRICS BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 148. EUROPEAN UNION BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 149. EUROPEAN UNION BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 150. EUROPEAN UNION BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 151. EUROPEAN UNION BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2018-2032 (USD MILLION)
TABLE 152. EUROPEAN UNION BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
TABLE 153. EUROPEAN UNION BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
TABLE 154. EUROPEAN UNION BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 155. ASEAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 156. ASEAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 157. ASEAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 158. ASEAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2018-2032 (USD MILLION)
TABLE 159. ASEAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
TABLE 160. ASEAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
TABLE 161. ASEAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 162. GCC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 163. GCC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 164. GCC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 165. GCC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2018-2032 (USD MILLION)
TABLE 166. GCC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
TABLE 167. GCC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
TABLE 168. GCC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 169. CHINA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 170. CHINA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 171. CHINA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 172. CHINA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2018-2032 (USD MILLION)
TABLE 173. CHINA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
TABLE 174. CHINA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
TABLE 175. CHINA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 176. UNITED STATES BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 177. UNITED STATES BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 178. UNITED STATES BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 179. UNITED STATES BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2018-2032 (USD MILLION)
TABLE 180. UNITED STATES BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
TABLE 181. UNITED STATES BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
TABLE 182. UNITED STATES BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 183. JAPAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 184. JAPAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 185. JAPAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 186. JAPAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2018-2032 (USD MILLION)
TABLE 187. JAPAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
TABLE 188. JAPAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
TABLE 189. JAPAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 190. INDIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 191. INDIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 192. INDIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 193. INDIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2018-2032 (USD MILLION)
TABLE 194. INDIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
TABLE 195. INDIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
TABLE 196. INDIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 197. GERMANY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 198. GERMANY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 199. GERMANY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 200. GERMANY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2018-2032 (USD MILLION)
TABLE 201. GERMANY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
TABLE 202. GERMANY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
TABLE 203. GERMANY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 204. UNITED KINGDOM BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 205. UNITED KINGDOM BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 206. UNITED KINGDOM BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 207. UNITED KINGDOM BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2018-2032 (USD MILLION)
TABLE 208. UNITED KINGDOM BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
TABLE 209. UNITED KINGDOM BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
TABLE 210. UNITED KINGDOM BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 211. AUSTRALIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 212. AUSTRALIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 213. AUSTRALIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 214. AUSTRALIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2018-2032 (USD MILLION)
TABLE 215. AUSTRALIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
TABLE 216. AUSTRALIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
TABLE 217. AUSTRALIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 218. FRANCE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 219. FRANCE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 220. FRANCE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 221. FRANCE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2018-2032 (USD MILLION)
TABLE 222. FRANCE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
TABLE 223. FRANCE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
TABLE 224. FRANCE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 225. SOUTH KOREA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 226. SOUTH KOREA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 227. SOUTH KOREA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 228. SOUTH KOREA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2018-2032 (USD MILLION)
TABLE 229. SOUTH KOREA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
TABLE 230. SOUTH KOREA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
TABLE 231. SOUTH KOREA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 232. ITALY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 233. ITALY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 234. ITALY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 235. ITALY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2018-2032 (USD MILLION)
TABLE 236. ITALY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
TABLE 237. ITALY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
TABLE 238. ITALY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 239. CANADA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 240. CANADA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 241. CANADA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 242. CANADA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2018-2032 (USD MILLION)
TABLE 243. CANADA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
TABLE 244. CANADA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
TABLE 245. CANADA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 246. RUSSIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 247. RUSSIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 248. RUSSIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 249. RUSSIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2018-2032 (USD MILLION)
TABLE 250. RUSSIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
TABLE 251. RUSSIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
TABLE 252. RUSSIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 253. BRAZIL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 254. BRAZIL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 255. BRAZIL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 256. BRAZIL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2018-2032 (USD MILLION)
TABLE 257. BRAZIL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
TABLE 258. BRAZIL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
TABLE 259. BRAZIL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 260. MEXICO BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 261. MEXICO BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 262. MEXICO BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 263. MEXICO BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2018-2032 (USD MILLION)
TABLE 264. MEXICO BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
TABLE 265. MEXICO BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
TABLE 266. MEXICO BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 267. SPAIN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 268. SPAIN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 269. SPAIN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 270. SPAIN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2018-2032 (USD MILLION)
TABLE 271. SPAIN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
TABLE 272. SPAIN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
TABLE 273. SPAIN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The companies featured in this Bio-Pharmaceutical Logistics market report include:
  • Agility Public Warehousing Company K.S.C.P.
  • Air Canada Cargo Inc.
  • Almac Group Limited
  • AmerisourceBergen Corporation
  • Biocair Limited
  • C.H. Robinson Worldwide, Inc.
  • Cardinal Health, Inc.
  • CEVA Logistics AG
  • Cryoport Inc.
  • DB Schenker
  • DHL Group
  • DSV Panalpina A/S
  • FedEx Corporation
  • GEODIS S.A.
  • Kerry Logistics Network Limited
  • Kuehne + Nagel International AG
  • MNX Global Logistics LLC
  • Movianto Group
  • Nippon Express Co., Ltd.
  • PCI Pharma Services Holdings LLC
  • QuickSTAT Global Life Science Logistics Inc.
  • SF Express Co., Ltd.
  • Thermo Fisher Scientific Inc.
  • United Parcel Service, Inc.
  • World Courier Inc.

Table Information

Report AttributeDetails
No. of Pages198
PublishedJune 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 102.56 Billion
Forecasted Market Value ( USD ) by 2032 $ 206.44 Billion
Compound Annual Growth Rate12.3%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Warehousing in Pharmaceutical Logistics Market - Global Forecast 2026-2032 - Product Image

Warehousing in Pharmaceutical Logistics Market - Global Forecast 2026-2032

  • Report
  • 192 Pages
  • Global
From
Pharmaceutical Logistics Market by Type, Product, Component, Mode of Transport, End User - Global Forecast 2026-2032 - Product Image

Pharmaceutical Logistics Market by Type, Product, Component, Mode of Transport, End User - Global Forecast 2026-2032

  • Report
  • 183 Pages
  • Global
From
Bio-pharma Logistics Market - Global Strategic Business Report - Product Image

Bio-pharma Logistics Market - Global Strategic Business Report

  • Report
  • 231 Pages
  • Global
From
Bio-Pharmaceutical Logistics Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Image

Bio-Pharmaceutical Logistics Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Bio-Pharmaceutical Logistics Market Report 2026 - Product Image

Bio-Pharmaceutical Logistics Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.